22-25221455-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BS1_SupportingBS2_Supporting
The NM_000496.3(CRYBB2):c.26C>T(p.Ala9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,613,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000496.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRYBB2 | NM_000496.3 | c.26C>T | p.Ala9Val | missense_variant | 2/6 | ENST00000398215.3 | NP_000487.1 | |
CRYBB2 | XM_006724141.4 | c.26C>T | p.Ala9Val | missense_variant | 2/6 | XP_006724204.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRYBB2 | ENST00000398215.3 | c.26C>T | p.Ala9Val | missense_variant | 2/6 | 1 | NM_000496.3 | ENSP00000381273 | P1 | |
CRYBB2 | ENST00000651629.1 | c.26C>T | p.Ala9Val | missense_variant | 2/6 | ENSP00000498905 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000757 AC: 19AN: 250918Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135740
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461398Hom.: 0 Cov.: 30 AF XY: 0.0000316 AC XY: 23AN XY: 727010
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74490
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2024 | The c.26C>T (p.A9V) alteration is located in exon 2 (coding exon 1) of the CRYBB2 gene. This alteration results from a C to T substitution at nucleotide position 26, causing the alanine (A) at amino acid position 9 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2017 | The c.26 C>T variant in the CRYBB2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The c.26 C>T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In-silico splice prediction models predict that c.26 C>T may create a cryptic splice donor site in exon 2. However, in the absence of RNA/functional studies, the actual effect of the c.26 C>T change in this individual is unknown. If c.26 C>T does not alter splicing, it will result in the A9V missense change. The A9V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret c.26 C>T as a variant of uncertain significance - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at